Respiratory Distress Syndrome, Newborn D012127

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Respiratory Distress Syndrome » Respiratory Distress Syndrome, Newborn

Diseases [C] » Respiratory Tract Diseases [C08] » Respiration Disorders » Respiratory Distress Syndrome » Respiratory Distress Syndrome, Newborn

Description

A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.   MeSH

Subtype Terms (2)

Hyaline Membrane Disease
7 drugs (6 approved, 1 experimental)

Transient Tachypnea of the Newborn
8 drugs (7 approved, 1 experimental)


Phase 4 Indicated Drugs (3)

Phase 3 Indicated Drugs (3)

Phase 1 Indicated Drugs (2)

Other Experimental Indicated Drugs (2)


Organization Involved with Phase 3 Indications (155)

Organization Involved with Phase 2 Indications (130)

Organization Involved with Other Experimental Indications (50)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.